News
Biotronik announced that the PK Papyrus covered coronary stent system has received CE mark for the treatment of acute coronary artery perforation.
November 11, 2013
Technology
SunTech Medical Advantage OEM non-invasive blood pressure (NIBP) modules provide reliable blood pressure measurement for adverse conditions during emergency medical service (EMS) transport.
November 11, 2013
News
Corindus Vascular Robotics presented a live percutaneous coronary intervention (PCI) during the Transcatheter Cardiovascular Therapeutics (TCT) conference on Oct. 29.
November 11, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
Researchers at Saint Luke’s Mid America Heart Institute led a study that showed marked, long-term improvement in health status in patients suffering from peripheral artery (PAD) treated with the SMART nitinol self-expandable stent.
November 11, 2013
News
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex Transseptal Guiding Sheath Kit device designed for catheterization specific heart chambers.
November 11, 2013
News
Zevacor Molecular, a healthcare firm that manufactures and distributes positron emissions tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A. (IBA).
November 08, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes — up to 180,000 per year — while using less medication overall, according to new research from the University of Michigan (U-M) Health System and the VA Ann Arbor Healthcare System.
November 08, 2013
Feature
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will drive rapid growth in the market for global left arterial appendage (LAA) closure devices.
November 08, 2013
Videos | Heart Valve Technology
Scott Lim, M.D., director of the Heart Valve Center at the University of Virginia Medical Center, investigator in the ...
November 07, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Videos
Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top ...
November 07, 2013
Feature
FDA Approves Medtronic Software for Use With Non-Medtronic Leads to Detect Defibrillator Lead Issues
Medtronic Inc. announced U.S. Food and Drug Administration (FDA) approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic leads.
November 07, 2013
Technology
Blackford Analysis, a provider of software products that accelerate comparison of medical images, announced it will launch its complete product range at the 2013 Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2013) in Chicago.
November 07, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
A Cedars-Sinai Heart Institute patient became the first in the nation to undergo the newly approved non-surgical procedure to fix their leaky and life-threatening heart valve condition.
November 07, 2013
Feature
The Cardiovascular Research Foundation (CRF) and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced the initiation of the Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT II) trial and the PROSPECT ABSORB sub study.
November 07, 2013
Technology
The U.S. Food and Drug Administration (FDA) approved Cardiovascular Systems Inc.’s Diamondback 360 Coronary Orbital Atherectomy System (OAS) for treatment of patients with severely calcified coronary lesions and who are candidates for percutaneous transluminal coronary angioplasty (PTCA) and have previously not been treated.
November 07, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now